Covidien plc·4

Feb 12, 4:04 PM ET

Covidien plc 4

4 · Covidien plc · Filed Feb 12, 2014

Insider Transaction Report

Form 4
Period: 2014-02-11
Wehrly Peter L
Senior Vice President
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2014-02-11$39.18/sh+8,286$324,64552,923 total
  • Sale

    Ordinary Shares

    2014-02-11$69.97/sh8,286$579,75444,637 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2014-02-118,2868,286 total
    Exercise: $39.18Exp: 2020-11-30Ordinary Shares (8,286 underlying)
Footnotes (2)
  • [F1]The price reported is the weighted average price. Shares were sold in multiple transactions at prices ranging from $69.9500 to $69.9800. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each price.
  • [F2]Options become exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary